Crossmark

QbD-Based Development of Translabial Bupropion-Loaded Nanoemulstick for Brain-Targeted Dopamine Modulation in Smoking Cessation using PC12 Cell Lines

Published Online: 2025-07-14

Published Print: 2025-08

Authors

Lata, Sneh

Nanda, Sanju
License Information

Text and Data Mining valid from 2025-07-14

Version of Record valid from 2025-07-14
More Information

Article History

Accepted: 28 June 2025

First Online: 14 July 2025

Declarations

:

: Not Applicable.

: The authors have approved the final version of the paper and declare that they have no conflicts of interest to report.

: The authors declare no competing interests.

Document is current